INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Option exerciseVerified data

Howe Jolanda reported MIRM

SVP, GLOBAL CONTROLLER · Mirum Pharmaceuticals, Inc. · Common Stock

Side
M
Value
—
Shares
1,500
Price
—
Executed
Jan 23, 2026
Disclosed
Jan 27, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 23 executedJan 27, 2026 disclosed

MIRM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 49.3% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · MIRM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    18
    PC
    Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.80M
    20.0K sh
    		Nov 4, 2026Nov 4, 2026
    traded Nov 4, 2026
    		+0dSEC FORM 4

    Evidence

    11
    PC
    Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M—
    20.0K sh
    		Nov 4, 2026Nov 4, 2026
    traded Nov 4, 2026
    		+0dSEC FORM 4

    Evidence

    6
    PC
    Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M$59K
    20.0K sh
    		Nov 4, 2026Nov 4, 2026
    traded Nov 4, 2026
    		+0dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M—
    16.1K sh
    		Oct 16, 2026Oct 19, 2026
    traded Oct 16, 2026
    		+3dSEC FORM 4

    Evidence

    23
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M$310K
    16.1K sh
    		Oct 16, 2026Oct 19, 2026
    traded Oct 16, 2026
    		+3dSEC FORM 4

    Evidence

    15
    MP
    Myers Robert PaulChief Medical Officer
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    25.0K sh
    		Oct 9, 2026Oct 14, 2026
    traded Oct 9, 2026
    		+5dSEC FORM 4

    Evidence

    15
    MP
    Myers Robert PaulChief Medical Officer
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    40.0K sh
    		Oct 9, 2026Oct 14, 2026
    traded Oct 9, 2026
    		+5dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M—
    40.0K sh
    		Aug 18, 2026Aug 19, 2026
    traded Aug 18, 2026
    		+1dSEC FORM 4

    Evidence

    38
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Open-market sale
    		SELL$4.00M
    40.0K sh
    		Aug 18, 2026Aug 19, 2026
    traded Aug 18, 2026
    		+1dSEC FORM 4

    Evidence

    23
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M$251K
    40.0K sh
    		Aug 18, 2026Aug 19, 2026
    traded Aug 18, 2026
    		+1dSEC FORM 4

    Evidence

    15
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$264K
    2,594 sh
    		Jun 17, 2026Jun 18, 2026
    traded Jun 17, 2026
    		+1dSEC FORM 4

    Evidence

    5
    QJ
    Quan JoanneCHIEF MEDICAL OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    11.8K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    7,680 sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    4,970 sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    9,000 sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    RP
    Radovich PeterPRESIDENT AND COO
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    25.1K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    QJ
    Quan JoanneCHIEF MEDICAL OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    18.1K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    QJ
    Quan JoanneCHIEF MEDICAL OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    20.0K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    RP
    Radovich PeterPRESIDENT AND COO
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    16.3K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    RP
    Radovich PeterPRESIDENT AND COO
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    34.5K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001974200-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 23, 2026
    Published
    Jan 27, 2026
    Ingested by INSIDER
    Nov 5, 04:20 UTC
    Last re-read
    Nov 5, 04:20 UTC

    Extracted facts

    Filer
    Howe Jolanda
    Role
    SVP, GLOBAL CONTROLLER
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Mirum Pharmaceuticals, Inc.
    Ticker
    MIRM
    Shares
    1,500
    Execution date (reported)
    Jan 23, 2026
    Owned after transaction
    4,542 shares
    Days from execution to publication
    4

    What this establishes

    Howe Jolanda filed this Form 4 reporting a option exercise of MIRM on Jan 23, 2026. It became public on Jan 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    SVP, GLOBAL CONTROLLER
    Howe Jolandacik:0001974200
    Issuer
    Mirum Pharmaceuticals, Inc.cik:0001759425

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.